Of the 72 patients, 63 cancer tissues (87.5%) and 54 pericarcinoma tissues (75.0%) expressed SOCS-1 mRNA (RI, 0.459±0.284 and 0.548±0.312, respectively; t=1.957, P=0.054). The gene discussed is SOCS1; the disease is cancer.